NHS National Framework for Denosumab Injection

Open

Buyers

Katy Reed

Value

£57,000,000

Classifications

Pharmaceutical products

Submission Deadline

2 weeks from now

Published

1 week ago

Description

Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026
Offer reference number: CM/TNS/25/5725
Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.   
CM/TNS/25/5725/01 - Regional award for Denosumab Injection:
NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) 
SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) 
MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)
LNW: (London) 01/01/2026 to 31/12/2026 (12 months)
CM/TNS/25/5725/02 - National award for Denosumab Injection:
7NAT (National) 01/01/2026 to 31/12/2026 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download